These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6703686)

  • 1. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.
    Harding SM; Williams PE; Ayrton J
    Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing.
    Sommers DK; Van Wyk M; Williams PE; Harding SM
    Antimicrob Agents Chemother; 1984 Mar; 25(3):344-7. PubMed ID: 6721467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
    Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
    Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
    Williams PE; Harding SM
    J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose and food on the bioavailability of cefuroxime axetil.
    Finn A; Straughn A; Meyer M; Chubb J
    Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefuroxime axetil.
    Marx MA; Fant WK
    Drug Intell Clin Pharm; 1988 Sep; 22(9):651-8. PubMed ID: 3063476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.
    Wise R; Bennett SA; Dent J
    J Antimicrob Chemother; 1984 Jun; 13(6):603-10. PubMed ID: 6469882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
    Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
    Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
    Ginsburg CM; McCracken GH; Petruska M; Olson K
    Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea.
    Wanas TM; Williams PE
    Genitourin Med; 1986 Aug; 62(4):221-3. PubMed ID: 3733084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
    Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
    J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the safety of cefuroxime axetil during six months oral administration to beagle dogs.
    Spurling NW; Harcourt RA; Hyde JJ
    J Toxicol Sci; 1986 Nov; 11(4):237-77. PubMed ID: 3820342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative investigations on the bioavailability of cefuroxime axetil.
    Kees F; Lukassek U; Naber KG; Grobecker H
    Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Dantzig AH; Duckworth DC; Tabas LB
    Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
    Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.